Chemogenomics
From Wikipedia, the free encyclopedia
Chemogenomics can be defined as a genomic response to chemical compounds. The goal is the rapid identification of novel drugs and drug targets embracing multiple early phase drug discovery technologies ranging from target identification and validation, over compound design and chemical synthesis to biological testing and ADME profiling.
[edit] See also
- Genomics
- Bioinformatics
- Cheminformatics
- Proteochemometrics
[edit] References
- Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, H. Kubinyi (Editor), G. Müller (Editor), R. Mannhold (Series Editor), G. Folkers (Series Editor), Wiley-VCH, 2004.ISBN 3-527-30987-X
[edit] External links
Topics in Medicinal Chemistry |
|---|
| ADME | Bioavailability | Chemogenomics | Drug Design | Drug Discovery | Enzyme Inhibition | Mechanism of Action | New Chemical Entity | Pharmacodynamics | Pharmacokinetics | Pharmacology | Pharmacophore | Quantitative Structure-Activity Relationship |
| Genomics topics |
| Genome project | Paleopolyploidy | Glycomics | Human Genome Project | Proteomics |
| Chemogenomics | Structural genomics | Pharmacogenetics | Pharmacogenomics | Toxicogenomics | Computational genomics |
| Bioinformatics | Cheminformatics | Systems biology |
ko:화학유전체학
